These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 6705899)

  • 41. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 42. Involvement of CYP2D6 in oxidative metabolism of cinnarizine and flunarizine in human liver microsomes.
    Narimatsu S; Kariya S; Isozaki S; Ohmori S; Kitada M; Hosokawa S; Masubuchi Y; Suzuki T
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1262-8. PubMed ID: 8323546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
    Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Physiological and toxicological aspects of metabolic activation of drugs].
    Szukalski B
    Acta Physiol Pol; 1984; 35 Suppl 27():36-81. PubMed ID: 6100809
    [No Abstract]   [Full Text] [Related]  

  • 45. [Possibilities of evaluating the activity of the drug biotransformation system in clinical pharmacology].
    Zolotareva TA
    Farmakol Toksikol; 1987; 50(3):121-6. PubMed ID: 3301398
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lipid dependence of cytochrome P-450 activity in rat liver microsomes using lipid exchange proteins].
    Diatlovitskaia EV; Petkova DKh; Lemenovskaia AF; Bergel'son LD
    Biokhimiia; 1982 Feb; 47(2):216-20. PubMed ID: 7066425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
    Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
    Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime.
    Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
    Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines in rifampicin-treated rabbit liver microsomes.
    Franklin MR
    Drug Metab Dispos; 1995 Dec; 23(12):1379-82. PubMed ID: 8689947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proceedings: Membrane effect on drug mono-oxygenation activity.
    Duppel W; Ullrich V
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1188. PubMed ID: 4461486
    [No Abstract]   [Full Text] [Related]  

  • 53. The P450 enzyme system: a key to understanding the metabolism of drugs.
    Bakutis AR
    AANA J; 1983 Jun; 51(3):272-4. PubMed ID: 6613503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo effects of the cytochrome P-450 suicide substrate 2-isopropyl-4-pentenamide (allylisopropylacetamide) on the disposition and metabolic pattern of propranolol.
    Silber B; Mico BA; Ortiz de Montellano PR; Dols DM; Riegelman S
    J Pharmacol Exp Ther; 1981 Oct; 219(1):125-33. PubMed ID: 7288600
    [No Abstract]   [Full Text] [Related]  

  • 55. [Uncoupling of the liver monooxygenase system by perfluorocarbons in vivo].
    Obraztsov VV; Shekhtman DG; Sklifas AN
    Biokhimiia; 1994 Aug; 59(8):1175-81. PubMed ID: 7819404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mechanism of oxidation of allylic alcohols to alpha,beta-unsaturated ketones by cytochrome P450.
    Bellucci G; Chiappe C; Pucci L; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):871-4. PubMed ID: 8828923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicological implications of drug metabolism.
    Welch RM
    Pharmacol Rev; 1978 Dec; 30(4):457-67. PubMed ID: 392540
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of the induction and inhibition of microsomal oxidases on the course of hemorrhagic shock].
    Levin GS; Kamenetskaia TsL
    Vestn Akad Med Nauk SSSR; 1985; (12):70-4. PubMed ID: 4090669
    [No Abstract]   [Full Text] [Related]  

  • 60. Enzyme induction.
    Dollery CT
    Br J Anaesth; 1972 Sep; 44(9):961-6. PubMed ID: 4564266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.